Symptomatic patients, ≤ 7 days since first symptom | |||||
RT-PCR (+) | RT-PCR (-) | Total | Sensitivity | 4.9% (1.0% to 13.7%) | |
IgM or IgG (+) | 3 | 5 | 8 | Specificity | 96.9% (92.9% to 99.0%) |
IgM or IgG r (-) | 58 | 157 | 215 | LR+ | 1.59 (0.39 to 6.47) |
Total | 61 | 162 | 223 | LR- | 0.98 (0.92 to 1.05) |
Symptomatic patients, 8 – 14 days | |||||
RT-PCR (+) | RT-PCR (-) | Total | Sensitivity | 27.3% (6.0% to 61.0%) | |
IgM or IgG (+) | 3 | 2 | 5 | Specificity | 98.7% (95.4% to 99.8%) |
IgM or IgG r (-) | 8 | 154 | 162 | LR+ | 21.27 (3.96 to 114.3) |
Total | 11 | 156 | 167 | LR- | 0.74 (0.51 to 1.06) |
Symptomatic patients ≥ 15 days | |||||
RT-PCR (+) | RT-PCR (-) | Total | Sensitivity | 57.8% (44.8% to 70.1%) | |
IgM or IgG (+) | 37 | 3 | 40 | Specificity | 98.4% (95.5% to 99.7%) |
IgM or IgG r (-) | 27 | 187 | 214 | LR+ | 36.6 (11.69 to 114.71) |
Total | 64 | 190 | 254 | LR- | 0.43 (0.32 to 0.57) |
RT-PCR = reverse transcriptase polymerase chain reaction; LR = likelihood ratio; IgM = immunoglobulin M; IgG = immunoglobulin G